|
|||
|
Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
|
Thursday, May 11
by
All About MS
on Thu 11 May 2006 08:00 AM CST
Patients with MS appear to experience more worry and anxiety related to the physical effect of the disease, social interactions and daily activities than do individuals who do not have MS, new trial data indicate.
To assess the nature of worry among more »
by
All About MS
on Thu 11 May 2006 07:34 AM CST
Results from a phase 3 study of the novel monoclonal antibody, natalizumab, show significant efficacy in reducing progression of disability and suppressing disease related changes in patients with multiple sclerosis (MS). Treatment with natalizumab resulted in a 42% reduction in disability progression over 2 years compared with more »
|
||